halting the neuroleptic , supportive care , and the use of dantrolene sodium and bromocriptine are the treatment modalities of choice for this syndrome , which has a mortality rate of 20 to 30 % and may be linked to malignant hyperthermia .
C0010977
dantrolene sodium
C0024591
malignant hyperthermia